Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer agents in participants with advanced cancer that has recurred/progressed.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent ma ogólnie dobry stan zdrowia, który nie pogorszył się w ciągu ostatnich dwóch tygodni.
- •Rak pacjenta postępuje w momencie przystąpienia do badania.
- •Pacjent ma prawidłowo działające narządy i szpik kostny.
- •U pacjenta zdiagnozowano nawrotowego zaawansowanego raka jajnika, jajowodu lub otrzewnej lub raka piersi z przerzutami, albo zaawansowanego raka prostaty lub trzustki, z potwierdzoną mutacją w określonych genach związanych z naprawą DNA.
- •Choroba pacjenta jest możliwa do oceny.
- •Pacjent nadaje się do leczenia lekiem typu PARPi (inhibitor PARP).
- •Pacjent potrafi zjeść posiłek wysokotłuszczowy i przestrzegać zaleceń dotyczących postu.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 130 Years
- Last updated (source)
- July 7, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (32)
Research Site
La Jolla, United States
Research Site
Los Angeles, United States
Research Site
San Francisco, United States
Research Site
Chicago, United States
Research Site
Boston, United States
Research Site
New York, United States
Research Site
New York, United States
Research Site
Portland, United States
Research Site
Houston, United States
Research Site
San Antonio, United States
Research Site
Richmond, United States
Research Site
Darlinghurst, Australia
Research Site
Melbourne, Australia
Research Site
Randwick, Australia
Research Site
Bayern, Germany
Research Site
Berlin, Germany
Research Site
Heidelberg, Germany
Research Site
Mainz, Germany
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
A Coruña, Spain
Research Site
Barcelona, Spain
Research Site
Málaga, Spain
Research Site
Pozuelo de Alarcón, Spain
Research Site
Sant Cugat del Vallès, Spain
Research Site
Seville, Spain
Research Site
Lund, Sweden
Research Site
Stockholm, Sweden
Research Site
Glasgow, Scotland, United Kingdom
Research Site
London, United Kingdom
Research Site
Newcastle upon Tyne, United Kingdom
Trial contact
AstraZeneca Clinical Study Information Center
AstraZeneca Breast Cancer Study Locator Service
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.